Abstract
Implication of computational techniques and in silico tools promote not only reduction of animal experimentations but also save time and money followed by rational designing of drugs as well as controlled synthesis of those “Hits” which show drug-likeness and possess suitable absorption, distribution, metabolism, excretion, and toxicity (ADMET) profile. With globalization of diseases, resistance of drugs over the time and modification of viruses and microorganisms, computational tools, and artificial intelligence are the future of drug design and one of the important areas where the principles of sustainability and green chemistry (GC) perfectly fit. Most of the new drug entities fail in the clinical trials over the issue of drug-associated human toxicity. Although ecotoxicity related to new drugs is rarely considered, but this is the high time when ecotoxicity prediction should get equal importance along with human-associated drug toxicity. Thus, the present book chapter discusses the available in silico tools and software for the fast and preliminary prediction of a series of human-associated toxicity and ecotoxicity of new drug entities to screen possibly safer drugs before going into preclinical and clinical trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Waring MJ, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, Pairaudeau G, Pennie WD, Pickett SD, Wang J, Wallace O, Weir A (2015) An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov 14:475–486
Jia C-Y, Li J-Y, Hao G-F, Yang G-F (2019) A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discov Today 25:248–258
Kar S, Leszczynski J (2017) Recent advances of computational modeling for predicting drug metabolism: a perspective. Curr Drug Metab 18:1106–1122
Lucas AJ, Sproston JL, Barton P, Riley RJ (2019) Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery. Expert Opin Drug Discov 14:1313–1327
Martiny VY, Carbonell P, Chevillard F, Moroy G, Nicot AB, Vayer P, Villoutreix BO, Miteva MA (2015) Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6. Bioinformatics 31:3930–3937
Grimm D (2019) EPA plan to end animal testing splits scientists. Science 365:1231
Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P (2021) Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers 12:1–46
Fleming N (2018) How artificial intelligence is changing drug discovery. Nature 557:S55–S57
Kar S, Leszczynski J (2020) Open access in silico tools to predict the ADMET profiling of drug candidates. Expert Opin Drug Discov 15:1473–1487
Dong J, Wang NN, Yao ZJ, Zhang L, Cheng Y, Ouyang D, Lu AP, Cao DS (2018) ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform 10:29
ADMETlab webserver. http://admet.scbdd.com/. Accessed on April 21, 2021
Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y (2012) admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 52:3099–3105
Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z, Li W, Liu G, Tang Y (2019) admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35:1067–1069
Tian S, Djoumbou-Feunang Y, Greiner R, Wishart DS (2018) CypReact: a software tool for in silico reactant prediction for human cytochrome P450 enzymes. J Chem Inf Model 58:1282–1291
CypReact webserver. https://bitbucket.org/Leon_Ti/cypreact/src/master/. Accessed on April 21, 2020
Shao CY, Su BH, Tu YS, Lin C, Lin OA, Tseng YJ (2015) CypRules: a rule-based P450 inhibition prediction server. Bioinformatics 31:1869–1871
CypRules Webserver. https://cyprules.cmdm.tw/. Accessed on April 21, 2021
Lagorce D, Bouslama L, Becot J, Miteva MA, Villoutreix BO (2017) FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics 33:3658–3660
FAF-Drugs tool. http://fafdrugs4.mti.univ-paris-diderot.fr/. Accessed on April 21, 2021
Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066–4072
pkCSM tool. http://biosig.unimelb.edu.au/pkcsm/. Accessed on April 21, 2021
Braga RC, Alves VM, Silva MF, Muratov E, Fourches D, Lião LM, Tropsha A, Andrade CH (2015) Pred-hERG: a novel web-accessible computational tool for predicting cardiac toxicity. Mol Inform 34:698–701
Pred-Herg tool. http://predherg.labmol.com.br/. Accessed on April 21, 2021
Borba JVB, Braga RC, Alves VM, Muratov EN, Kleinstreuer N, Tropsha A, Andrade CH (2021) Pred-skin: a web portal for accurate prediction of human skin sensitizers. Chem Res Toxicol 34:258–267
Pred-Skin 3.0 app. http://predskin.labmol.com.br/. Accessed on April 21 2021
Banerjee P, Eckert OA, Schrey AK, Preissner R (2018) ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 46:W257–W263
ProTox-II webserver. https://tox-new.charite.de/protox_II/. Accessed on April 21 2021
MolPort database. (2021). www.molport.com. Accessed on 21 April 2021
SwissADME webserver. http://swissadme.ch/. Accessed on 21 April 2021
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717
Schyman P, Liu R, Desai V, Wallqvist A (2017) vNN web server for ADMET predictions. Front Pharmacol 8:889
vNN-ADMET webserver. https://vnnadmet.bhsai.org/vnnadmet/login.xhtml?status=error. Accessed on 21 April 2021
Zaretzki J, Matlock M, Swamidass SJ (2013) XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks. J Chem Inf Model 53:3373–3383
XenoSite tool. https://swami.wustl.edu/xenosite/submit. Accessed on 21 April 2021
Öeren M, Walton PJ, Hunt PA, Ponting DJ, Segall MD (2021) Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTs. J Comput Aided Mol Des 35:541–555
Hughes TB, Miller GP, Swamidass SJ (2015) Modeling epoxidation of drug-like molecules with a deep machine learning network. ACS Cent Sci 1:168–180
Hughes TB, Swamidass SJ (2017) Deep learning to predict the formation of Quinone species in drug metabolism. Chem Res Toxicol 30:642–656
Hughes TB, Miller GP, Swamidass SJ (2015) Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione. Chem Res Toxicol 28:797–809
Dang NL, Hughes TB, Krishnamurthy V, Swamidass SJ (2016) A simple model predicts UGT-mediated metabolism. Bioinformatics 32:3183–3189
Lagunin A, Filimonov D, Poroikov V (2010) Multi-targeted natural products evaluation based on biological activity prediction with PASS. Curr Pharm Des 16:1703–1717
Way2Drug webserver. http://www.pharmaexpert.ru/passonline/. Accessed on 21 April 2021
Bocci G, Carosati E, Vayer P, Arrault A, Lozano S, Cruciani G (2017) ADME-space: a new tool for medicinal chemists to explore ADME properties. Sci Rep 7:6359
Yang M, Chen J, Xu L, Shi X, Zhou X, Xi Z, An R, Wang X (2018) A novel adaptive ensemble classification framework for ADME prediction. RSC Adv 8:11661–11683
Kar S, Roy K (2013) How far can virtual screening take us in drug discovery? Expert Opin Drug Discov 8:245–261
Kapusta K, Kar S, Collins JT, Franklin LM, Kolodziejczyk W, Leszczynski J, Hill GA (2021) Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic & dynamic, and ADMET profiling. J Biomol Struct Dyn 39:6810–6827
Ojha PK, Mitra I, Kar S, Narayan Das R, Roy K (2012) Lead hopping for PfDHODH inhibitors as Antimalarials based on pharmacophore mapping, molecular docking and comparative binding energy analysis (COMBINE): a three-layered virtual screening approach. Mol Inform 31:711–718
Pushpakom S, Iorio F, Eyers P, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41–58
Rao PPN, Pham AT, Shakeri A, El Shatshat A, Zhao Y, Karuturi RC, Hefny AA (2021) Drug repurposing: dipeptidyl peptidase IV (DPP4) inhibitors as potential agents to treat SARS-CoV-2 (2019-nCoV) infection. Pharmaceuticals 14:44
Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J (2016) BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 44:D1045–D1063
BindingDB database. https://www.bindingdb.org/bind/index.jsp. Accessed on 21 April 2021
ChEMBL database. https://www.ebi.ac.uk/chembl/. Accessed on 21 April 2021
CompTox Chemicals Dashboard. https://comptox.epa.gov/dashboard. Accessed on 21 April 2021
DrugBank database. https://go.drugbank.com/. Accessed on 21 April 2021
PKKB database. http://cadd.zju.edu.cn/pkkb/. Accessed on 21 April 2021
Banerjee P, Erehman J, Gohlke BO, Wilhelm T, Preissner R, Dunkel M (2015) Super Natural II: a database of natural products. Nucleic Acids Res 43:D935–D939
Super Natural II database. http://bioinf-applied.charite.de/supernatural_new/. Accessed on 21 April 2021
Russell WMS, Burch RL (1959) The principles of humane experimental technique. Methuen, London
Acknowledgments
SK and JL want to acknowledge the National Science Foundation (Grant: NSF/CREST HRD-1547754) to support the research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kar, S., Roy, K., Leszczynski, J. (2022). In Silico Tools and Software to Predict ADMET of New Drug Candidates. In: Benfenati, E. (eds) In Silico Methods for Predicting Drug Toxicity. Methods in Molecular Biology, vol 2425. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1960-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1960-5_4
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1959-9
Online ISBN: 978-1-0716-1960-5
eBook Packages: Springer Protocols